Revolution Medicines, Inc.
(RVMD - NASDAQ)
132,83 USD
📋 Profilo Aziendale

Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers.

|